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Background: The treatment of cocaine-dependent individuals (CDI) is substantially chal-
lenged by high drop-out rates, raising questions regarding contributing factors. Recently,
a number of studies have highlighted the potential of greater focus on the clinical signifi-
cance of neurocognitive impairments in treatment-seeking cocaine users. In the present
study, we hypothesized that disadvantageous decision-making would be one such factor
placing CDI at greater risk for treatment drop-out.
Methods: In order to explore this hypothesis, the present study contrasted baseline perfor-
mance (at treatment onset) on two validated tasks of decision-making, the Iowa Gambling
Task (IGT) and the Cambridge GambleTask (CGT) in CDI who completed treatment in a resi-
dentialTherapeutic Community (TC) (N =66) and those who dropped out ofTC prematurely
(N = 84).
Results: Compared to treatment completers, CDI who dropped out of TC prematurely did
not establish a consistent and advantageous response pattern as the IGT progressed and
exhibited a poorer ability to choose the most likely outcome on the CGT. There were no
group differences in betting behavior.
Conclusion: Our findings suggest that neurocognitive rehabilitation of disadvantageous
decision-making may have clinical benefits in CDI admitted to long-term residential
treatment programs.
Keywords: decision-making, drop-out, treatment retention, addiction treatment outcomes, cocaine dependence
INTRODUCTION
The treatment of cocaine-dependent individuals (CDI) is sub-
stantially challenged by high drop-out rates. Whereas treatment
attrition is high across the majority of substance abuse treat-
ment studies, drop-out rates ranging from 60 to 80% have been
reported among CDI (1–3). These high drop-out rates are partic-
ularly problematic, given the well-established association between
the length of time spent in treatment (i.e., treatment reten-
tion) and post-treatment outcomes. More specifically, a suffi-
cient length of time spent in the treatment program constitutes
one of the strongest and most consistent predictors of positive
post-treatment outcomes, including sustained abstinence (4, 5).
Conversely, CDI who drop-out of treatment prematurely fare
worse than those who stay in treatment for the entire period:
high drop-out rates limit overall treatment effectiveness, increase
the propensity to relapse and seriously exacerbate health, finan-
cial, and legal consequences (6, 7). This relationship between
treatment drop-out/completion and post-treatment outcomes has
been found across all the major addiction treatment modalities (8–
10), including drug-free inpatient therapeutic communities (TCs),
which remain a core modality of the drug treatment system in
Europe and the United States (11, 12).
The high attrition rates observed among CDI and their
detrimental consequences raise questions regarding contributing
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factors that might influence treatment drop-out in this population.
Finding a way to predict premature treatment drop-out could help
in the early identification of CDI with the highest risk for drop-out,
such that these individuals may receive additional monitoring and
adequate therapeutic interventions targeting specific risk factors.
A recent generation of research, facilitated by considerable
advances in the field of neuroscience, has begun to examine
whether neurocognitive impairments in CDI may confer an
increased risk of drop-out (13, 14). Indeed, growing evidence indi-
cating that a substantial number of CDI suffer from detectable
damage in cortical and sub-cortical brain regions and exhibit
deficits across a range of neurocognitive domains (15, 16) has
recently encouraged researchers to focus on neurocognitive factors
when attempting to predict treatment drop-out. Although prelim-
inary, these studies seem to suggest that CDI who drop-out of treat-
ment prematurely demonstrate significantly poorer performance
than treatment completers across various cognitive domains,
including attention, memory, and processing speed (13, 14, 17). As
such, intact executive functioning may be a necessary prerequisite
to successfully complete treatment or attain treatment objectives.
Surprisingly, very few studies have focused on the prognos-
tic utility of more specific aspects of neurocognitive functioning,
such as those related to the domain of (affective) decision-making
(18, 19). This lack of research is particularly striking given the
well-established role of impaired decision-making in the patho-
genesis and pathophysiology of addiction (20, 21). A substantial
number of drug-dependent individuals shows behavioral signs
of disadvantageous decision-making, characterized by a prefer-
ence for immediate rewards while disregarding long-term conse-
quences (a pattern coined “myopia for the future”), despite these
choices being less adaptive with regard to overall expected value
(22, 23). For example, neurocognitive assessment using the Iowa
Gambling Task (IGT) (24) has shown that drug-dependent indi-
viduals are more likely to make maladaptive decisions, resulting in
long-term losses exceeding short-term gains (25). Similarly, evi-
dence suggests that a number of drug-dependent individuals fail
to improve their performance on this task based on trial-by-trial
outcomes (26). Using alternative probes of decision-making which
minimize learning requirements (i.e., decision-making under risk
rather than under ambiguous conditions), other studies showed
that drug-dependent individuals demonstrated an increased ten-
dency to choose the less likely outcome, despite having processed
information regarding outcome probabilities (27).
Over the years, numerous studies have established the ecolog-
ical and predictive validity of disadvantageous decision-making
in drug users (26, 28, 29). In particular, poor decision-making
in drug-dependent individuals has shown significant correlations
with real-life everyday functioning, including social impairment,
problems with maintaining gainful employment, and difficulties
with achieving and maintaining substantial periods of abstinence
(26, 28, 30–32). Hypothetically, a decision-making style charac-
terized by impaired integration of affective/cognitive information
into future strategies (i.e., poor learning from experience) or
an immediate reward preference disregarding long-term future
consequences may also put CDI at greater risk for premature
treatment drop-out. However, despite the intuitive appeal of such
a relationship, the association between poor decision-making
and premature treatment drop-out among CDI has remained
underexplored.
To the best of our knowledge, only two studies – including
one of our own research group – have examined the relation-
ship between disadvantageous decision-making and treatment
outcomes in CDI (19, 32). Both studies used the length of stay
in treatment as the outcome variable of interest and found that
disadvantageous decision-making, as indexed by lower IGT net
scores, was unrelated to treatment retention among these indi-
viduals (19, 32). However, treatment retention and drop-out have
recently been found to be predicted by different variables (11) and
as such, it remains unknown whether and how disadvantageous
decision-making in CDI relates to treatment drop-out. Further,
by selectively focusing on overall IGT net scores, previous reten-
tion studies did not differentiate between distinct components of
decision-making.
With the present study, we aimed to refine our initial findings
by introducing a number of relevant novelties compared to pre-
vious research: first, we used treatment drop-out (rather than the
number of days in treatment) as the outcome variable of interest.
Further, to better parse some important components of decision-
making that may be relevant to treatment drop-out, the present
study utilized two complementary decision-making measures: the
IGT, which factors reward/punishment-based decision-making
learning, and the Cambridge Gamble Task (CGT) (27), which fac-
tors risk-based decision-making outside a learning context. We
hypothesized that impaired decision-making, as indexed by (1) a
failure to develop a preference for the advantageous decks during
the course of the IGT and (2) poor decision-making on the CGT,
would be associated with treatment drop-out among primarily
CDI admitted to residential TCs.
MATERIALS AND METHODS
PARTICIPANTS
Eligible participants were recruited from six different TCs located
in the region of Andalusia (Spain): Cartaya, Almonte, Mijas, Los
Palacios, La Línea, and Tarifa. All TCs had a common treatment
program that is based on multidisciplinary interventions, includ-
ing Cognitive Behavioral Therapy (CBT), psycho-education, and
occupational therapy. More details regarding the recruitment con-
text of this study have been described elsewhere [see Verdejo-
Garcia et al. (29)]. For inclusion, participants had to (1) meet
the DSM-IV-TR for cocaine dependence and report cocaine as
their primary substance of abuse, (2) be able to understand test
instructions and perform the neuropsychological assessment, and
(3) be abstinent for at least 15 days (in order to avoid poten-
tial effects of acute intoxication or withdrawal symptoms on
neurocognitive task performance). Individuals meeting the cri-
teria for nicotine or heroin dependence and/or alcohol abuse
were also included. Exclusion criteria included dependence on
other substances (e.g., other opioids, benzodiazepines, cannabi-
noids, barbiturates, hallucinogenics) and being abstinent for more
than 2 months. DSM-criteria were determined using the Spanish
version of the Psychiatric Research Interview for Substance and
Mental Disorders (33). Information about the frequency, amount,
and duration of drug use was collected using the Interview for
Research on Addictive Behavior (IRAB) (34).
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ASSESSMENT PROCEDURE
After the clinical staff had screened potential participants for inclu-
sion criteria, individuals were informed about the aims of the study
and provided written informant consent. The study was approved
by the Comité de Ética en Investigación Humana (CEIH) of the
University of Granada. A baseline neuropsychological assessment
was performed between day 20 and 30 following treatment entry.
Assessment of decision-making was undertaken by an experienced
neuropsychologist in a quiet testing environment in each of the six
different TCs.
DECISION-MAKING ASSESSMENT
The IGT is a computer task that requires individuals to choose
from four decks of cards, decks A, B, C, and D. Unbeknownst to
the participants, two decks (i.e., A and B) are associated with large
wins but even larger losses (resulting in net loss), whereas the other
two decks (i.e., C and D) are associated with smaller wins but also
smaller losses (resulting in overall profit). During the course of the
task, healthy participants usually develop a preference for the safe
decks (C and D). In contrast, individuals with impaired decision-
making often continue to choose cards from the risky decks (A and
B), which in the long run, will take more money than they give. The
100 trials were grouped into five blocks of 20 consecutive cards,
with a net score for each block calculated as (C+D)− (A+B)
decks. Calculating net scores for each block of 20 trials permits an
analysis of learning across the different phases of the IGT. An over-
all IGT net score was also determined by adding up the individual
block scores. Selecting more cards from bad decks results in an
overall net loss across the 100 trials of the task, whereas choosing
more cards from the good decks results in overall net gains.
The Cambridge Gamble Task (CGT) of the CANTABeclipse
Battery is a computerized task in which participants are presented
with a row of 10 boxes at the top of the screen, each of which
can be either red or blue. At the bottom of the screen are rec-
tangles containing the words “Red” and “Blue.” Participants are
instructed to guess whether a yellow token is hidden in a red box
or a blue box. After making a choice, participants are asked to place
a bet on this choice being correct. Available bets are offered in a
sequence, as a proportion of the participant’s points total on that
trial (ascending condition: 5, 25, 50, 75, 95%; descending condi-
tion: 95, 75, 50, 25, 5%). After the bet is placed, the hidden token
is revealed and the bet is added to or subtracted from the total
score. Dependent measures were (1) quality of decision-making
(i.e., the percentage of trials subjects bet on the more likely out-
come), (2) risk-taking (the mean proportion of current points
total that the subject stakes on each gamble test trial for which
they had chosen the more likely outcome), (3) deliberation time
(average response time to make the probability decision), and (4)
risk adjustment (the rate at which participants increase their bets
in response to the more favorable ratios blue/red). Healthy con-
trols usually adjust their bet according to the ratio of red and
blue boxes; that is, betting fewer points if the odds of winning are
lower. Finally, a comparison of the proportion of points bet in
the ascending and descending condition enables an assessment of
delay aversion. In particular, delay-aversive individuals will place
low bets in the ascending condition, coupled with high bets in the
descending condition. In contrast, individuals with a preference
for risk will typically delay their response to place high bets in the
ascending condition.
OPERATIONAL DEFINITION OF TREATMENT DROP-OUT
Duration of treatment in TCs can range from 6 months up until
2 years. Different from our previous study in CDI (19), we coded
treatment retention in the present study as a binary variable: treat-
ment completion vs. drop-out. More specifically, we differentiated
those participants who completed treatment in the TC and all
of the objectives that were laid out at the beginning of treat-
ment (treatment completers) from those that left the program
prematurely (drop-outs).
STATISTICAL ANALYSIS
Data were first screened for normality and univariate outliers. Dif-
ferences between treatment completers and drop-outs on demo-
graphic, drug use and decision-making variables were tested
using independent sample t -tests for continuous variables (e.g.,
years of education) and chi-square analyses for categorical data
(e.g., gender). In order to examine whether treatment completers
and drop-outs differed in decision-making performance, we per-
formed Block*Group mixed-design ANOVAs for the IGT (Block-
by-Block) and Condition*Group designs for the CGT (Ascending
vs. Descending conditions). When the assumption of sphericity
was violated, as assessed using the Mauchly sphericity test, the
number of degrees of freedom against which the F-ratio was tested
was reduced by the value of the Greenhouse–Geisser epsilon (35).
The third set of analyses looked at the degree to which variables
that significantly differed between treatment completers and drop-
outs predicted treatment drop-out. For these analyses, we used a
logistic regression analysis with drop-out as the dependent vari-
able and the main demographic, drug use and decision-making
variables as the predictors. Variables significant in the initial (uni-
variate) regression analyses were simultaneously entered into the
final logistic regression model (enter method), designed to deter-
mine whether these predictors were independently associated
with treatment drop-out. Multicollinearity diagnostic statistics
for the logistic model (tolerance values and VIF) were examined
to exclude multicollinearity due to interdependency between the
predictor variables. We calculated the classification accuracy of the
final model. All analyses were performed using SPSS, version 20.0.
RESULTS
PARTICIPANTS
A total of 150 patients were included in the present analyses.
Results indicated that more than half of the sample dropped out of
treatment prematurely (84/150; 56%), compared to 44% (66/150)
who completed treatment. The mean length of stay in TC treat-
ment for the entire sample was 150.15 days (SD= 77.04); there
were significant differences between the patients who completed
treatment and those who did not. In particular, treatment com-
pleters had a mean stay of 207.61 days (SD= 64.54), whereas drop-
outs had a mean stay of 105 days (SD= 52) (t = 10.78, p< 0.01).
The demographic and drug-related characteristics/differences
between treatment completers and non-completers are presented
in Table 1. Groups did not differ in terms of gender (χ2= 0.28,
df= 1, p= 0.60) or years of education (t =−0.33, p= 0.74).
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Table 1 | Descriptive information for demographic variables, patterns of cocaine, heroin, and other drug use in treatment completers (N =66)
and drop-outs (N =84).
Treatment completers (N =66) Drop-outs (N =84)
Demographics Gender (% male/female) 94/6 92/8
Age 37.73±8.34* 34.87±8.09
Years of education 10.61±2.47 10.74±2.43
Drug use Cocaine use
Age of first use 19.08±4.99 18.96±5.07
Age of onset problem use 22.29±6.18 20.86±5.57
Years of regular use 18.65±7.82* 15.90±6.95
Mean use per week (days) 5.02±1.07 5.06±1.01
Mean amount per use (g) 0.81±0.66 0.82±0.81
Peak amount per use (g) 2.40±2.17 2.56±2.65
Route of administration
Oral (%) / 1/84
Sniffed (%) 20/66 23/84
Injected (%) 10/66 8/84
Smoked (%) 36/66 51/84
Inhaled (%) / 1/84
Heroin use (71.3%) 45/66 (68%) 62/84 (74%)
Age of first use 21.53±5.89 20.60±4.72
Age of onset problem use 23.04±7.01 21.73±6.25
Years of regular use 12.42±8.35 10.10±7.08
Mean use per week (days) 4.87±1.39 4.53±1.39
Mean amount per use (g) 0.39±0.49 0.28±0.28
Peak amount per use (g) 0.91±0.85 0.70±0.61
Other drug use past 30 days
Cannabis 26/66 (39.39%) 29/84 (34.52%)
Alcohol 36/66 (54.55%) 44/84 (52.38%)
Stimulants 3/66 (4.55%) 2/84 (2.38%)
Hallucinogens 1/66 (1.52%) 0/84
Benzodiazepines 13/66 (19.70%) 21/84 (25%)
Results shown are mean±SD (range) or %.
*p<0.05.
However, treatment completers and drop-outs significantly dif-
fered in terms of their mean age, with drop-outs being signifi-
cantly younger (34.87± 8.09) compared to treatment completers
(37.73± 8.34) (t = 2.12, p= 0.04). Most drug-related variables
did not differ between treatment completers and drop-outs. The
only drug-related variable that differed significantly in both groups
was the years of regular cocaine use, with drop-outs having a
briefer history of regular cocaine use (years) compared to those
who completed treatment (15.90± 6.95 compared to 18.65± 7.82
respectively; t = 2.28, p= 0.02).
IOWA GAMBLING TASK
Analyzing the IGT-profile of the entire sample using ANOVA
repeated measures, we found a significant effect of block [F(3.62,
535.08)= 8.46, p< 0.01]. The pattern of net score change over
block was significantly linear (p< 0.01). Overall, these results
indicate that participants made more advantageous choices as
the task progressed. However, when the effect of block was
examined individually for treatment completers and drop-outs
(separate repeated-measures ANOVAs for each group), we found
that the main effect of block was only significant among treatment
completers [repeated-measures ANOVA, effect of block F(3.09,
200.77)= 6.90, p< 0.01)]. In contrast, the drop-out group did not
improve their performance as the task progressed [F(4,80)= 1.66,
p= 0.17] (Figure 1). Results showed a trend for a block*group
interaction [F(3.62, 535.08)= 2.06, p= 0.09]. Pairwise block-by-
block between-group comparisons showed that performance of
treatment completers and drop-outs significantly differed on the
last (fifth) block of the IGT: drop-outs (M net score=−0.3) selected
significantly more often cards from the disadvantageous decks
than treatment completers (M net score= 2.9) during this block
(t = 2.24, p= 0.03) (Table 2).
CAMBRIDGE GAMBLE TASK
Quality of decision-making
There was no significant effect of condition [F(1,148)= 1.70,
p= 0.19] on the quality of decision-making. However, we found
a statistically significant group effect [F(1,148)= 5.89, p= 0.02].
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FIGURE 1 | Performance on the Iowa GamblingTask (IGT) as a function
of group (drop-outs vs. treatment completers) and blocks (1–5). Each
block (1–5) represents 20 sequential card selections. Net score is calculated
by subtracting the number of disadvantageous deck selections (A+B) from
the number of advantageous card selections (C+D). A negative net score
indicates poor decision making. Compared to treatment completers,
individuals in the drop-out group tended to select more cards from the risky
decks (A and B) than from the safe decks (C and D), although this difference
only reached statistical significance in the fifth block (last 20 trials).
Whereas a post hoc analysis showed that, compared to treat-
ment completers, the drop-out group made poorer decisions in
the ascending condition (t = 2.78, p< 0.01) (see Table 2), group
by condition interaction was not significant [F(1,148)= 1.81,
p= 0.18].
Deliberation time
Deliberation time was not affected by condition [F(1,148)< 1,
p= 0.58] and between-subject analysis did not reveal a group
effect [F(1,148)< 1, p= 0.99].
Risk-taking
A mixed-model ANOVA of betting data identified a significant
main effect of condition [F(1,148)= 227.46, p< 0.01], as sub-
jects placed larger bets in the descending (mean 67%) than in the
ascending condition (mean 41%). There was no significant effect
of group (treatment completers and drop-outs did not differ in
the mean proportion of total points they staked on each gam-
ble test trial for which they had chosen the more likely outcome)
[F(1,148)< 1, p= 0.77] and group by condition (ascending vs.
descending) interaction terms were not significant [F(1,148)= 1,
p= 0.32]. This finding suggests that both groups did not differ in
their tendency to take an early bet, which provides an index of
impulsivity or delay aversion.
Risk adjustment
A mixed-model ANOVA of risk-adjustment data identified a sig-
nificant main effect of condition [F(1,148)= 20.75, p< 0.01],
with subjects showing more adjustment of their bets in
the ascending condition. There was no significant effect of
group [F(1,148)< 1, p= 0.66] or group*condition interaction
Table 2 | Decision-making variables.
Treatment
Completers
(N =66)
Drop-outs
(N =84)
IGT
Net scores 2.1±21.8 −3±23.5
Block 1 −2.9±6.3 −2.1±6.3
Block 2 −0.5±6.1 −0.7±6.4
Block 3 1.9±7.2 0.1±7.5
Block 4 0.7±8.6 0.1±7
Block 5 2.9±9.1* −0.3±8.2
CGT
Quality of decision-making (%) 91.4±9.1* 86.6±13.7
Ascending condition 91.4±9.7 85.3±15.5
Descending condition 91.4±10.8 87.9±15.0
Risk-taking 0.5±0.1 0.5±0.1
Ascending condition 0.4±0.2 0.4±0.2
Descending condition 0.9±0.1 0.9±0.2
Deliberation time (ms) 4506.2±4989.9 4512.5±4352.8
Risk adjustment 1.1±0.8 1.07±0.8
Results shown are mean±SD.
*p<0.05.
[F(1,148)< 1, p= 0.99]. As such, there were no differences
between treatment completers and drop-outs in the extent to
which they adapted their bets according to the ratio of colored
boxes.
PREDICTION OF TREATMENT DROP-OUT
Variables that significantly differed between treatment completers
and drop-outs were tested for their predictive capacity. For the
demographical and drug-related variables, these were age and
years of regular cocaine use (see Table 1). For the decision-
making variables, we included performance on block 5 of the
IGT (as block-by-block comparison showed significant differences
between treatment completers and drop-outs on this block, see
Iowa Gambling Task) and mean scores on CGT quality of decision-
making (as a repeated measure ANOVA showed a significant group
effect on the quality of decision-making, see Cambridge Gam-
ble Task). Initial analyses of the data seemed to support the idea
that age (χ2= 4.48, df= 1, p= 0.03), years of regular cocaine use
(χ2= 5.16, df= 1, p= 0.02), IGT net scores on block 5 (χ2= 4.96,
df= 1, p= 0.03) and CGT quality of decision-making (χ2= 6.29,
df= 1, p= 0.01) were all significant predictors of treatment drop-
out. Due to the high correlations between age and years of regular
cocaine use (r = 0.80, p= 0.01), age was not retained for multi-
variate regression. A logistic regression analysis was conducted to
predict treatment drop-out using years of regular cocaine use, IGT
net scores on block 5, and CGT quality of decision-making as pre-
dictors. Collinearity statistics for the predictor variables yielded
tolerance values between 0.94 and 0.99 and all VIF values were
below 10, indicating that the validity of the regression model was
not threatened by multicollinearity. A test of the full model against
a constant only model was statistically significant, indicating that
the predictors as a set reliably distinguished between treatment
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completers and drop-outs (χ2= 13.51, df= 3; p< 0.01). Nagelk-
erke’s R2 of 0.12 indicated that the three predictors explained
about 12% of the total variance in treatment drop-out. Prediction
success for drop-out was 75%. The Wald criterion demonstrated
that only the two decision-making variables made a significant
(independent) contribution to prediction (p= 0.05) (Table 3). A
stepwise backward regression (likelihood ratio test) showed that
the goodness of fit of the model did not change significantly
when years of regular cocaine use was removed. Removing this
variable from the initial model moreover slightly improved the
classification accuracy of drop-outs (from 75 to 77.5%). The stan-
dardized beta-coefficients, Wald statistics and significance levels
for the predictors included in the two models are displayed in
Tables 3 and 4.
DISCUSSION
The present study is the first to examine the relationship between
two validated tasks of decision-making and treatment drop-out
in a relatively large (n= 150) and unselected sample of primar-
ily CDI enrolled in long-term residential TCs. Our main finding
is that performance on two tasks of decision-making, the IGT
and CGT, was significantly related to and predictive of treatment
drop-out. Results suggest that after entering long-term residen-
tial treatment for cocaine dependence, intact decision-making
processes may be crucial to adhere to treatment and complete
treatment objectives.
In general, individuals choose increasingly from the advanta-
geous decks as the IGT progresses (20, 24). In corroboration with
this normative trend, our sample showed improvements over the
course of the tasks as an entire group. However, when split into
treatment completers and drop-outs, we found that only treat-
ment completers showed an improvement as the IGT progressed
(these individuals ultimately had positive “money” gains). In con-
trast, the drop-out group did not select more frequently from the
advantageous decks, ultimately lost “money” and displayed min-
imal evidence of learning to select from the advantageous decks
across the task, as suggested by their (still) negative net scores on
block 5 of the IGT (last 20 trials). Conceptually, the later blocks
of the IGT have been suggested to represent post-learning stages
(players presumably have developed explicit knowledge of the risk
profile across IGT alternatives) and performance on these blocks is
believed to reflect decision-making under risk (rather than ambi-
guity) (36). This notion has been supported by a number of studies
pointing to significant correlations between later stage IGT selec-
tions and an individual’s propensity for deliberate risk-taking (36,
37). However, recent evidence indicates that these correlations may
not be present among high-impulsive individuals, potentially sug-
gesting that this group fails to develop explicit knowledge of risky
IGT alternatives (37).
The finding that drop-outs failed to develop a preference for
the advantageous decks and continued to select cards from the
bad decks, despite being penalized, may suggest several things.
First, this group may be less sensitive to or may fail to gen-
erate emotion-related signals (somatic markers) to losing (38).
These somatic markers normally facilitate advantageous decisions
by steering away from options that, through prior experience,
are associated with unpleasant gut feelings (39). Hypothetically,
Table 3 | Multivariate prediction of treatment drop-out with a logistic
regression model.
Predictors B SE Wald statistics p-Value
Years of regular cocaine use −0.04 0.02 2.63 0.10
IGT block 5 −0.04 0.02 3.78 0.05
CGT quality of decision-making −3.28 1.71 3.68 0.05
Table 4 | Final prediction model.
Predictors B SE Wald statistics p-Value
IGT block 5 −0.04 0.02 4.35 0.04
CGT quality of decision-making −0.04 0.02 5.01 0.02
weaker somatic signals to negative outcomes in CDI may lead
them to be less hesitant about terminating treatment prematurely.
However, a number of alternative theories have been proposed to
explain impaired decision-making in drug-dependent individuals,
including poor working memory and cognitive flexibility (40). As
the fixed card order on the IGT induces an initial preference for
the ultimately risky decks, disadvantageous performance in the
drop-out group may reflect a difficulty in reversing behaviors that
may once have been rewarding but ultimately bring high costs,
such as continued drug use. Corroborating this notion, signifi-
cant associations between poor decision-making on the IGT and
difficulties with achieving and maintaining abstinence have been
reported among individuals dependent on cocaine, opiates, and
alcohol (30–32, 41, 42).
Using an alternative task of decision-making (CGT) that is
not confounded by information processing demands, we were
able to show that drop-outs were less likely to choose the most
favorable option (i.e., the box color in the majority) compared
to treatment completers. These choices reflect low quality deci-
sions, given that the probabilities associated with each choice
are visible at the time of the decision. As both groups equally
used the box ratio information about outcome probability to
adjust their bets (as shown by the absence of significant dif-
ferences in adjustment slopes across groups), findings indirectly
suggest that the lower-quality decisions in the drop-out group
cannot be attributed to poor processing of probability informa-
tion. A comparison of betting behavior in the ascending and
descending condition between drop-outs and treatment com-
pleters further suggests that poor decision-making in the drop-out
group was not due to greater delay aversion or impulsivity. In
fact, both groups showed evidence of impulsive responding, as
indicated by the significantly higher bets placed in the descend-
ing condition. Finally, the absence of differences between both
groups in terms of deliberation time argues against an explana-
tion in terms of speed-accuracy. Overall, our findings suggest
that drop-out vulnerable cocaine users fail to integrate prior
experiences into their decisions or neglect probability informa-
tion, thus ignoring the broader context in which decisions are
made. These deficits may be associated with alterations in the
orbitofrontal and the ventromedial prefrontal cortex (regions
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implicated in the use of feedback to improve decision-making)
or the dorsolateral prefrontal loop, which has a critical role in
overseeing subordinate processes through the exercise of executive
control (36, 43).
CLINICAL IMPLICATIONS
Our findings have important clinical implications. If replicated,
the present results suggest that (1) tasks indexing decision-making
may be added to the range of clinical information that is collected
at treatment intake in order to identify CDI who are at risk for
premature treatment drop-out and that (2) treatment drop-out
among CDI admitted to TCs may be reduced by targeting cognitive
and affective processes involved in decision-making.
In line with the multiple processes implicated in the regula-
tion of decision-making, the integrity of prefrontal cortical, and
executive functioning in general and aspects involved in risk-
reward decision-making (executive functioning, reversal learning
and interoceptive awareness) in particular represent interesting
targets for consideration (44). Whereas more research is needed
in order to examine the feasibility of incorporating these inter-
ventions into real-world clinical settings, preliminary evidence
suggests that a combination of executive functioning training (e.g.,
Goal Management Training) and mindfulness-based meditation
(45) and/or emotion regulation techniques (46, 47) may have
the potential to improve adaptive decision-making in drug users.
Importantly, these strategies should be modified and employed
in a manner that specifically appeals to or targets cognitively
impaired subgroups of drug users. Indeed, some of these interven-
tions assume a certain level of cognitive ability needed to acquire
skills, such that patients who are substantially cognitively impaired
may be less likely to benefit from them. Similarly, neurocog-
nitive dysfunctions, including disadvantageous decision-making,
have been linked to both structural and functional brain alter-
ations, which are likely to compromise learning and successful
behavioral modification during treatment (48). Therefore, phar-
macological interventions or neuromodulation-based approaches
(e.g., Transcranial Magnetic Stimulation) aimed at upregulating
brain functioning (48–50) may provide neurocognitively impaired
drug users with a stronger ability to benefit from cognitively
oriented treatment programs. Modafinil for example, could act
as a successful adjunct for increasing the effectiveness of exec-
utive training programs in cognitively impaired drug users by
boosting neural functioning in regions implicated in learning
and cognitive control (i.e., insula, ventromedial prefrontal, and
anterior cingulate cortices). However, the effectiveness of com-
bining these approaches has yet to be systematically explored
and reported on and might be a promising area for future
research.
STUDY LIMITATIONS
Although we believe that the current study has important clin-
ical implications, several limitations should also be noted. First,
several factors should be considered before generalizing from our
findings. Specifically, our findings are based on a predominantly
male sample of poly-drug-using CDI, the majority of whom were
crack users, enrolled in long-term, residential TCs. Drug users
admitted to TCs often have relatively severe problems, prior drug
abuse treatment experience, and a criminal justice status. As such,
the present findings may not extrapolate to other treatment sam-
ples (e.g., women, individuals enrolled in outpatient treatment
settings). Still, it should be noted that our sample represents a
group of CDI encountered in real clinical contexts, which increases
the ecological validity of the study results. Despite our finding
that two indices of decision-making predicted treatment drop-
out, there was a significant amount of variance that was not
accounted for by the variables examined in this study. Impor-
tantly, we did not take into account the effects of other potentially
relevant person-related factors, such as psychiatric comorbidity,
personality (e.g., impulsivity, perseverance), or intellectual func-
tioning (51–54). Further, drop-out from treatment is not driven
purely by person-related factors (actually, person-related vari-
ables typically predict only a small proportion of the variance in
drop-out), but also varies as a function of treatment-related vari-
ables and interactions between the individual and the treatment
environment (30, 31, 55).
We did not examine potential mediators of both cognitive per-
formance and treatment retention. Among many other factors,
motivation may have functioned as a mediator of both apparent
cognitive performance as well as treatment retention: motivation
has been shown to be an important factor in treatment reten-
tion among substance-dependent individuals (56–58) and lower
motivation to change has been found to correlate with poorer
performance on a task of decision-making (59). As such, it is pos-
sible that the observed differences in cognitive task performance
between treatment completers and drop-outs reflect a difference
in motivation for treatment and in the motivation to perform
well on the decision-making tasks. Also, our data do not exclude
the possibility that motivation for treatment or motivation to
change functioned as a mediator of the relationship between disad-
vantageous decision-making and treatment drop-out. Indeed, the
way in which neurocognitive dysfunctions impact upon treatment
outcomes may not necessarily be direct (60). Rather, neurocogni-
tive impairments can impede treatment outcomes through their
effects on treatment processes or more intrapersonal factors (60).
For example, poor neurocognitive functioning has shown sig-
nificant associations with lower motivation to change or poorer
self-efficacy in treatment samples of alcoholics (61, 62). These
countervailing effects of neurocognitive dysfunctions on intrap-
ersonal processes may cancel out when analyzing direct effects of
impairment on treatment drop-out. Future studies may help to
better understand the nature of the current findings by examining
a range of potential mediators, including motivation.
In summary, the present study is the first to show that pri-
marily CDI who drop-out of residential treatment prematurely
fail/neglect to integrate prior experiences/knowledge regarding
outcome probabilities into their decisions. Further, our findings
indirectly suggest that previous studies may have failed to find
associations between IGT performance and treatment retention
because early and late IGT selections were combined into a sin-
gle measure and changes in task performance were not taken into
account. Whereas the precise underlying processes contributing to
disadvantageous decision-making patterns remain to be explored,
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our findings have potential implications for the treatment of
cocaine dependence.
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